{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T02:39:45Z","timestamp":1776307185716,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","award":["PL2024H017"],"award-info":[{"award-number":["PL2024H017"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Genet Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00438-026-02416-0","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T01:41:36Z","timestamp":1776303696000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SND1 regulates the androgen signaling axis by stabilizing EIF3B mRNA to facilitate the deterioration of prostate cancer"],"prefix":"10.1007","volume":"301","author":[{"given":"Ying","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengru","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoli","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiliang","family":"Gui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linlin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honglin","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2608-7688","authenticated-orcid":false,"given":"Hua","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"issue":"3","key":"2416_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 74(3):229\u2013263 21834. PubMed PMID: 38572751","journal-title":"Cancer J Clin"},{"issue":"1","key":"2416_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/jnci\/djz099","volume":"112","author":"A Husby","year":"2020","unstructured":"Husby A, Wohlfahrt J, Melbye M (2020) Vasectomy and Prostate Cancer Risk: A 38-Year Nationwide Cohort Study. Jnci-Journal Natl Cancer Inst 112(1):71\u201377. https:\/\/doi.org\/10.1093\/jnci\/djz099PubMed PMID: WOS:000510453200012","journal-title":"Jnci-Journal Natl Cancer Inst"},{"issue":"5","key":"2416_CR3","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s11764-017-0637-9","volume":"11","author":"K Kim","year":"2017","unstructured":"Kim K, Kim JS (2017) Intervention for patient reported urinary symptoms in prostate cancer survivors: Systematic review. J Cancer Surviv 11(5):643\u2013654. https:\/\/doi.org\/10.1007\/s11764-017-0637-9PubMed PMID: WOS:000410817800011","journal-title":"J Cancer Surviv"},{"key":"2416_CR4","doi-asserted-by":"publisher","unstructured":"Sekhoacha M, Riet K, Motloung P, Gumenku L, Adegoke A, Mashele S (2022) Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches. Molecules 27(17). https:\/\/doi.org\/10.3390\/molecules27175730PubMed PMID: WOS:000851891400001","DOI":"10.3390\/molecules27175730"},{"issue":"2","key":"2416_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.eururo.2024.04","volume":"86","author":"D Tilki","year":"2024","unstructured":"Tilki D, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J et al (2024) EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer. Eur Urol 86(2):164\u2013182 Epub 2024\/05\/01. https:\/\/doi.org\/10.1016\/j.eururo.2024.04","journal-title":"Eur Urol"},{"issue":"6","key":"2416_CR6","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/iju.15424","volume":"31","author":"D Obinata","year":"2024","unstructured":"Obinata D, Takayama K, Inoue S, Takahashi S (2024) Exploring androgen receptor signaling pathway in prostate cancer: A path to new discoveries. Int J Urol 31(6):590\u2013597. https:\/\/doi.org\/10.1111\/iju.15424PubMed PMID: WOS:001160427900001","journal-title":"Int J Urol"},{"key":"2416_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-1-61779-243-4_2","volume":"776","author":"D Wang","year":"2011","unstructured":"Wang D, Tindall DJ (2011) Androgen action during prostate carcinogenesis. Methods in molecular biology. (Clifton NJ) 776:25\u201344. https:\/\/doi.org\/10.1007\/978-1-61779-243-4_2PubMed PMID: MEDLINE:21796518","journal-title":"(Clifton NJ)"},{"key":"2416_CR8","doi-asserted-by":"publisher","first-page":"S695","DOI":"10.21037\/tcr.2018.05.42","volume":"7","author":"CS Spina","year":"2018","unstructured":"Spina CS (2018) Androgen deprivation therapy and radiation therapy for prostate cancer: the mechanism underlying therapeutic synergy. Translational Cancer Res 7:S695\u2013S703. https:\/\/doi.org\/10.21037\/tcr.2018.05.42PubMed PMID: WOS:000442853700007","journal-title":"Translational Cancer Res"},{"issue":"6","key":"2416_CR9","doi-asserted-by":"publisher","first-page":"189018","DOI":"10.1016\/j.bbcan.2023.189018","volume":"1878","author":"W Jia","year":"2023","unstructured":"Jia W, Yuan J, Li S, Cheng B (2023) The role of dysregulated mRNA translation machinery in cancer pathogenesis and therapeutic value of ribosome-inactivating proteins. Biochim et Biophys acta Reviews cancer 1878(6):189018 Epub 2023\/11\/10. https:\/\/doi.org\/10.1016\/j.bbcan.2023.189018","journal-title":"Biochim et Biophys acta Reviews cancer"},{"issue":"1","key":"2416_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12935-022-02578-y","volume":"22","author":"C Xu","year":"2022","unstructured":"Xu C, Shen Y, Shi Y, Zhang M, Zhou L (2022) Eukaryotic translation initiation factor 3 subunit B promotes head and neck cancer via CEBPB translation. Cancer Cell Int 22(1):161 Epub 2022\/04\/24. https:\/\/doi.org\/10.1186\/s12935-022-02578-y","journal-title":"Cancer Cell Int"},{"issue":"5","key":"2416_CR11","first-page":"2188","volume":"13","author":"Y Li","year":"2023","unstructured":"Li Y, Zhao J, Yuan Z, Yuan D, Fang M, Xie M et al (2023) Eukaryotic initiation factor 3b regulates the development and progression of breast cancer. Am J cancer Res 13(5):2188\u20132200 Epub 2023\/06\/09. PubMed PMID: 37293180; PubMed Central PMCID: PMCPMC10244105","journal-title":"Am J cancer Res"},{"key":"2416_CR12","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.biopha.2018.10.027","volume":"109","author":"L Wang","year":"2019","unstructured":"Wang L, Ouyang L, Biomedicine (2019) pharmacotherapy = Biomedecine pharmacotherapie 109:831\u2013837 Epub 2018\/12\/16. https:\/\/doi.org\/10.1016\/j.biopha.2018.10.027","journal-title":"pharmacotherapy = Biomedecine pharmacotherapie"},{"issue":"7\u20138","key":"2416_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00335-020-09842-4","volume":"31","author":"P Xiang","year":"2020","unstructured":"Xiang P, Sun Y, Fang Z, Yan K, Fan Y (2020) Eukaryotic translation initiation factor 3 subunit b is a novel oncogenic factor in prostate cancer. Mammalian genome: official J Int Mammalian Genome Soc 31(7\u20138):197\u2013204 Epub 2020\/06\/20. https:\/\/doi.org\/10.1007\/s00335-020-09842-4","journal-title":"Mammalian genome: official J Int Mammalian Genome Soc"},{"issue":"11","key":"2416_CR14","doi-asserted-by":"publisher","first-page":"4566","DOI":"10.7150\/ijbs.100905","volume":"20","author":"Y Wu","year":"2024","unstructured":"Wu Y, Peng S, Cheng B, Zhong H, Cen M, Fu J et al (2024) FOXA1-dependent PUS1 regulates EIF3b stability in a non-enzymatic pathway mediating prostate cancer bone metastasis. Int J Biol Sci 20(11):4566\u20134584 Epub 2024\/09\/09. https:\/\/doi.org\/10.7150\/ijbs.100905","journal-title":"Int J Biol Sci"},{"issue":"12","key":"2416_CR15","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1158\/2159-8290.Cd-23-0306","volume":"13","author":"S Santasusagna","year":"2023","unstructured":"Santasusagna S, Zhu S, Jawalagatti V, Carceles-Cordon M, Ertel A, Garcia-Longarte S et al (2023) Master Transcription Factor Reprogramming Unleashes Selective Translation Promoting Castration Resistance and Immune Evasion in Lethal Prostate Cancer. Cancer Discov 13(12):2584\u20132609 Epub 2023\/09\/07. https:\/\/doi.org\/10.1158\/2159-8290.Cd-23-0306","journal-title":"Cancer Discov"},{"key":"2416_CR16","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3389\/fonc.2018.00606","volume":"8","author":"B Ochoa","year":"2018","unstructured":"Ochoa B, Chico Y, Mart\u00ednez MJ (2018) Insights Into SND1 Oncogene Promoter Regulation. Front Oncol 8:606 Epub 2019\/01\/09. doi: 10.3389\/fonc.2018.00606. PubMed PMID: 30619748; PubMed Central PMCID: PMCPMC6297716","journal-title":"Front Oncol"},{"issue":"1","key":"2416_CR17","doi-asserted-by":"publisher","first-page":"7435","DOI":"10.1038\/s41467-023-43245-8","volume":"14","author":"SY Liao","year":"2023","unstructured":"Liao SY, Rudoy D, Frank SB, Phan LT, Klezovitch O, Kwan J et al (2023) SND1 binds to ERG and promotes tumor growth in genetic mouse models of prostate cancer. Nat Commun 14(1):7435 Epub 2023\/11\/17. https:\/\/doi.org\/10.1038\/s41467-023-43245-8","journal-title":"Nat Commun"},{"key":"2416_CR18","doi-asserted-by":"publisher","unstructured":"Qin X, Zhong J, Wang L, Chen Z, Liu X (2023) LncRNA LNC-565686 Promotes Proliferation of Prostate Cancer by Inhibiting Apoptosis through Stabilizing SND1. Biomedicines 11(10). https:\/\/doi.org\/10.3390\/biomedicines11102627PubMed PMID: 37893001; PubMed Central PMCID: PMCPMC10603871 Epub 2023\/10\/28","DOI":"10.3390\/biomedicines11102627"},{"issue":"6","key":"2416_CR19","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.2353\/ajpath.2009.080776","volume":"174","author":"H Kuruma","year":"2009","unstructured":"Kuruma H, Kamata Y, Takahashi H, Igarashi K, Kimura T, Miki K et al (2009) Staphylococcal nuclease domain-containing protein 1 as a potential tissue marker for prostate cancer. Am J Pathol 174(6):2044\u20132050 PubMed PMID: 19435788; PubMed Central PMCID: PMCPMC2684170","journal-title":"Am J Pathol"},{"issue":"1","key":"2416_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13046-023-02684-3","volume":"42","author":"J Zheng","year":"2023","unstructured":"Zheng J, Zhang Q, Zhao Z, Qiu Y, Zhou Y, Wu Z et al (2023) Epigenetically silenced lncRNA SNAI3-AS1 promotes ferroptosis in glioma via perturbing the m(6)A-dependent recognition of Nrf2 mRNA mediated by SND1. J Exp Clin Cancer Res 42(1):127 Epub 2023\/05\/19. https:\/\/doi.org\/10.1186\/s13046-023-02684-3","journal-title":"J Exp Clin Cancer Res"},{"key":"2416_CR21","doi-asserted-by":"publisher","unstructured":"Zhao Y, Ren P, Yang Z, Wang L, Hu C (2023) Inhibition of SND1 overcomes chemoresistance in bladder cancer cells by promoting ferroptosis. Oncology reports. ;49(1). Epub 2022\/12\/02. https:\/\/doi.org\/10.3892\/or.2022.8453. PubMed PMID: 36453257; PubMed Central PMCID: PMCPMC9773013","DOI":"10.3892\/or.2022.8453"},{"key":"2416_CR22","doi-asserted-by":"publisher","unstructured":"Aurilio G, Cimadamore A, Mazzucchelli R, Lopez-Beltran A, Verri E, Scarpelli M et al (2020) Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications. Cells. ;9(12). Epub 2020\/12\/17. https:\/\/doi.org\/10.3390\/cells9122653. PubMed PMID: 33321757; PubMed Central PMCID: PMCPMC7763510","DOI":"10.3390\/cells9122653"},{"issue":"5","key":"2416_CR23","doi-asserted-by":"publisher","first-page":"158589","DOI":"10.1016\/j.bbalip.2019.158589","volume":"1865","author":"H Navarro-Imaz","year":"2020","unstructured":"Navarro-Imaz H, Ochoa B, Garc\u00eda-Arcos I, Mart\u00ednez MJ, Chico Y, Fresnedo O et al (2020) Molecular and cellular insights into the role of SND1 in lipid metabolism. Biochim et Biophys acta Mol cell biology lipids 1865(5):158589 Epub 2020\/01\/25. https:\/\/doi.org\/10.1016\/j.bbalip.2019.158589","journal-title":"Biochim et Biophys acta Mol cell biology lipids"},{"issue":"6","key":"2416_CR24","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.1016\/j.ygeno.2020.06.044","volume":"112","author":"X Cui","year":"2020","unstructured":"Cui X, Zhang X, Liu M, Zhao C, Zhang N, Ren Y et al (2020) A pan-cancer analysis of the oncogenic role of staphylococcal nuclease domain-containing protein 1 (SND1) in human tumors. Genomics 112(6):3958\u20133967 Epub 2020\/07\/10. https:\/\/doi.org\/10.1016\/j.ygeno.2020.06.044","journal-title":"Genomics"},{"issue":"1","key":"2416_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s43018-021-00279-5","volume":"3","author":"M Shen","year":"2022","unstructured":"Shen M, Wei Y, Kim H, Wan L, Jiang YZ, Hang X et al (2022) Small-molecule inhibitors that disrupt the MTDH-SND1 complex suppress breast cancer progression and metastasis. Nat Cancer 3(1):43\u201359 Epub 2022\/02\/06. https:\/\/doi.org\/10.1038\/s43018-021-00279-5","journal-title":"Nat Cancer"},{"issue":"1","key":"2416_CR26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s43018-021-00280-y","volume":"3","author":"M Shen","year":"2022","unstructured":"Shen M, Smith HA, Wei Y, Jiang YZ, Zhao S, Wang N et al (2022) Pharmacological disruption of the MTDH-SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer. Nat Cancer 3(1):60\u201374 Epub 2022\/02\/06. https:\/\/doi.org\/10.1038\/s43018-021-00280-y","journal-title":"Nat Cancer"},{"issue":"3","key":"2416_CR27","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1007\/s13577-020-00364-4","volume":"33","author":"J Wang","year":"2020","unstructured":"Wang J, Hu Y, Ye C, Liu J (2020) miR-1224-5p inhibits the proliferation and invasion of ovarian cancer via targeting SND1. Hum Cell 33(3):780\u2013789 Epub 2020\/05\/16. https:\/\/doi.org\/10.1007\/s13577-020-00364-4","journal-title":"Hum Cell"},{"issue":"1","key":"2416_CR28","doi-asserted-by":"publisher","first-page":"111809","DOI":"10.1016\/j.yexcr.2019.111809","volume":"388","author":"F Zhan","year":"2020","unstructured":"Zhan F, Zhong Y, Qin Y, Li L, Wu W, Yao M (2020) SND1 facilitates the invasion and migration of cervical cancer cells by Smurf1-mediated degradation of FOXA2. Exp Cell Res 388(1):111809 Epub 2020\/01\/01. https:\/\/doi.org\/10.1016\/j.yexcr.2019.111809","journal-title":"Exp Cell Res"},{"issue":"6508","key":"2416_CR29","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.aba4904","volume":"369","author":"J Brito Querido","year":"2020","unstructured":"Brito Querido J, Sokabe M, Kraatz S, Gordiyenko Y, Skehel JM, Fraser CS et al (2020) Structure of a human 48S translational initiation complex. Sci (New York NY) 369(6508):1220\u20131227 Epub 2020\/09\/05. https:\/\/doi.org\/10.1126\/science.aba4904","journal-title":"Sci (New York NY)"},{"issue":"12","key":"2416_CR30","doi-asserted-by":"publisher","first-page":"e112362","DOI":"10.15252\/embj.2022112362","volume":"42","author":"H Duan","year":"2023","unstructured":"Duan H, Zhang S, Zarai Y, \u00d6llinger R, Wu Y, Sun L et al (2023) eIF3 mRNA selectivity profiling reveals eIF3k as a cancer-relevant regulator of ribosome content. EMBO J 42(12):e112362 Epub 2023\/05\/08. https:\/\/doi.org\/10.15252\/embj.2022112362","journal-title":"EMBO J"},{"issue":"7","key":"2416_CR31","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s10529-020-02878-1","volume":"42","author":"L Huang","year":"2020","unstructured":"Huang L, Wei Z, Chang X, Zheng X, Yan J, Huang J et al (2020) eIF3b regulates the cell proliferation and apoptosis processes in chronic myelogenous leukemia cell lines via regulating the expression of C3G. Biotechnol Lett 42(7):1275\u20131286 Epub 2020\/04\/03. https:\/\/doi.org\/10.1007\/s10529-020-02878-1","journal-title":"Biotechnol Lett"},{"issue":"8","key":"2416_CR32","doi-asserted-by":"publisher","first-page":"7311","DOI":"10.18632\/aging.205759","volume":"16","author":"R Huang","year":"2024","unstructured":"Huang R, Nie W, Mi L, Yao C, Zhu H (2024) EIF3B stabilizes PCNA by counteracting SYVN1-mediated ubiquitination to serve as a promotor in cholangiocarcinoma. Aging 16(8):7311\u20137330 Epub 2024\/04\/30. https:\/\/doi.org\/10.18632\/aging.205759","journal-title":"Aging"},{"issue":"12","key":"2416_CR33","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1111\/cas.15543","volume":"113","author":"P Fang","year":"2022","unstructured":"Fang P, Han Y, Qu Y, Wang X, Zhang Y, Zhang W et al (2022) EIF3B stabilizes PTGS2 expression by counteracting MDM2-mediated ubiquitination to promote the development and progression of malignant melanoma. Cancer Sci 113(12):4181\u20134192 Epub 2022\/09\/02. https:\/\/doi.org\/10.1111\/cas.15543","journal-title":"Cancer Sci"},{"key":"2416_CR34","doi-asserted-by":"publisher","unstructured":"Reiss AB, Gulkarov S, Pinkhasov A, Sheehan KM, Srivastava A, De Leon J et al (2023) Androgen Deprivation Therapy for Prostate Cancer: Focus on Cognitive Function and Mood. Medicina (Kaunas. Lithuania) 60(1). https:\/\/doi.org\/10.3390\/medicina60010077PubMed PMID: 38256338; PubMed Central PMCID: PMCPMC10819522 Epub 2024\/01\/23","DOI":"10.3390\/medicina60010077"},{"issue":"1","key":"2416_CR35","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s13046-023-02777-z","volume":"42","author":"M Zhang","year":"2023","unstructured":"Zhang M, Kan D, Zhang B, Chen X, Wang C, Chen S et al (2023) P300\/SP1 complex mediating elevated METTL1 regulates CDK14 mRNA stability via internal m7G modification in CRPC. J Exp Clin Cancer Res 42(1):215 Epub 2023\/08\/21. https:\/\/doi.org\/10.1186\/s13046-023-02777-z","journal-title":"J Exp Clin Cancer Res"},{"key":"2416_CR36","doi-asserted-by":"crossref","unstructured":"Siegel DA, O\u2019Neil ME, Richards TB, Dowling NF, Weir HK (2020) Prostate Cancer Incidence and Survival, by Stage and Race\/Ethnicity - United States, 2001\u20132017. MMWR Morbidity and mortality weekly report. ;69(41):1473-80. Epub 2020\/10\/16. doi: 10.15585\/mmwr.mm6941a1. PubMed PMID: 33056955; PubMed Central PMCID: PMCPMC7561091 Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed","DOI":"10.15585\/mmwr.mm6941a1"},{"issue":"1","key":"2416_CR37","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1158\/1541-7786.Mcr-14-0273","volume":"13","author":"AG Sowalsky","year":"2015","unstructured":"Sowalsky AG, Xia Z, Wang L, Zhao H, Chen S, Bubley GJ et al (2015) Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer. Mol cancer research: MCR 13(1):98\u2013106 Epub 2014\/09\/06. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-14-0273","journal-title":"Mol cancer research: MCR"},{"issue":"1","key":"2416_CR38","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13046-022-02404-3","volume":"41","author":"L Chen","year":"2022","unstructured":"Chen L, Song Y, Hou T, Li X, Cheng L, Li Y et al (2022) Circ_0004087 interaction with SND1 promotes docetaxel resistance in prostate cancer by boosting the mitosis error correction mechanism. J experimental Clin cancer research: CR 41(1):194 Epub 2022\/06\/07. https:\/\/doi.org\/10.1186\/s13046-022-02404-3","journal-title":"J experimental Clin cancer research: CR"}],"container-title":["Molecular Genetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-026-02416-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00438-026-02416-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-026-02416-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T01:41:37Z","timestamp":1776303697000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00438-026-02416-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2416"],"URL":"https:\/\/doi.org\/10.1007\/s00438-026-02416-0","relation":{},"ISSN":["1617-4615","1617-4623"],"issn-type":[{"value":"1617-4615","type":"print"},{"value":"1617-4623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is no conflict of interest in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All experiments were approved by the Bioethics and Medical Ethics Committee of Jiamusi University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"97"}}